Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

NCT00547586 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Constipation

Interventions

DRUG: N-methylnaltrexone bromide (MOA-728)
OTHER: placebo

Sponsor

Bausch Health Americas, Inc.

Collaborators

[object Object]